title: Other inflammatory markers should not be forgetten when assessing the neutrophil-to-lymphocyte ratio.
authors.affiliation: 1Department of Cardiology, Gulhane Medical Academy, Ankara, Turkey.
authors.forename: Sevket
authors.initials: S
authors.lastname: Balta
authors.forename: Sait
authors.initials: S
authors.lastname: Demirkol
authors.forename: Mustafa
authors.initials: M
authors.lastname: Cakar
authors.forename: Zekeriya
authors.initials: Z
authors.lastname: Arslan
authors.forename: Murat
authors.initials: M
authors.lastname: Unlu
authors.forename: Turgay
authors.initials: T
authors.lastname: Celik
mesh_terms: D015415:Biomarkers / Q000097:blood; D018450:Disease Progression; D006801:Humans; D007249:Inflammation / Q000097:blood*; D018655:Lymphocyte Count; D008214:Lymphocytes / Q000378:metabolism*; D009504:Neutrophils / Q000378:metabolism*; D012307:Risk Factors
chemical_list: D015415:Biomarkers